Emerging Drugs For Central Nervous System - Tim Dyer, CEO, Addex Therapeutics Ltd 00:00:00

Share On Facebook Share On Twitter

Addex Therapeutics co-founder and CEO Tim Dyer speaks to Thomas Warner from Proactive about the work that the central nervous system-focused clinical-stage pharmaceutical company has been doing in the promising area of allosteric modulation.

Recent Videos